| View |
|
DR-XY14079
|
Propranolol Hydrochloride
|
Inderal® 40 Mg Tablet
|
40 mg
|
Tablet
|
Non-selective Beta-adrenoreceptor Blocker
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Automatic Renewal
|
26 July 2023
|
10 August 2028
|
| View |
|
DR-XY14117
|
Mecobalamin
|
Methycobal
|
500 mcg
|
Tablet
|
Vitamin
|
Interphil Laboratories
|
Philippines
|
Renewal
|
30 May 2022
|
18 November 2027
|
| View |
|
DR-XY1413
|
Haloperidol Decanoate
|
Haldol Decanoas
|
50 mg/mL
|
Solution for Injection (IM)
|
-
|
GlaxoSmithKline Manufacturing S.p.A.
|
Italy
|
-
|
04 March 2021
|
16 February 2026
|
| View |
|
DR-XY14144
|
Dimenhydrinate
|
None
|
12.5 mg/5 mL
|
Syrup
|
-
|
Drugmakers Laboratories, Inc.
|
Philippines
|
-
|
30 April 2020
|
19 January 2025
|
| View |
|
DR-XY14154
|
Budesonide
|
Budecort Respules®
|
500 mcg/mL (1000 mcg/2 mL)
|
Nebulizing Suspension (Sterile)
|
-
|
AstraZeneca AB
|
Sweden
|
-
|
26 December 2019
|
20 February 2025
|
| View |
|
DR-XY14162
|
Metronidazole
|
None
|
500mg
|
Solution for IV Infusion
|
-
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
-
|
18 December 2020
|
09 February 2026
|
| View |
|
DR-XY14274
|
Nicardipine Hydrochloride
|
Cardepine
|
1 mg/mL (10 mg/10 mL)
|
Solution For Injection (Iv)
|
-
|
Amherst Parenterals, Inc.
|
Philippines
|
-
|
26 August 2020
|
29 October 2025
|
| View |
|
DR-XY14293
|
Iron (as ferrous sulfate)
|
Brisofer
|
75 mg
|
Capsule
|
HEMATINIC
|
San Marino Laboratories Corp.
|
Philippines
|
Automatic Renewal
|
18 June 2023
|
23 May 2028
|
| View |
|
DR-XY14300
|
Erythromycin
|
None
|
5 mg/g (0.5% w/w)
|
Ophthalmic Ointment
|
Antibacterials (Macrolides)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 May 2023
|
08 December 2028
|
| View |
|
DR-XY14359
|
Miconazole Nitrate
|
Daktarin
|
20 mg/g
|
Cream
|
Antifungal
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 July 2022
|
23 June 2027
|
| View |
|
DR-XY14361
|
Miconazole
|
Daktarin
|
20 mg/g
|
Oral Gel
|
Antifungal
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
29 November 2023
|
30 December 2028
|
| View |
|
DR-XY14395
|
Polymyxin B Sulfate + Neomycin Sulfate + Dexamethasone
|
Postop
|
1.25mg/ 3.5mg/ 1mg per mL
|
Ophthalmic Suspension (Drops)
|
Antibacterial /Steroidal Anti-inflammatory
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
17 June 2022
|
01 July 2026
|
| View |
|
DR-XY14400
|
Diclofenac Sodium
|
Diclowal 75
|
25mg/mL
|
Solution for Injection (I.M.)
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Walter Ritter GmbH Co.
|
Germany
|
Automatic Renewal
|
17 June 2021
|
12 May 2026
|
| View |
|
DR-XY14429
|
Mannitol
|
Osmofundin
|
20%
|
Solution For I.V. Infusion
|
Osmotic Diuretic Agent
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
Renewal
|
24 January 2024
|
14 May 2029
|
| View |
|
DR-XY14481
|
Tobradex + Dexamethasone
|
Tobradex
|
3mg/ 1mg per mL
|
Sterile Ophthalmic Suspension
|
Antibacterial/ Anti-Inflammatory
|
Alcon-Couvreur N.V.
|
Belgium
|
Automatic Renewal
|
29 March 2022
|
04 February 2027
|
| View |
|
DR-XY14607
|
Alprazolam
|
Xanor
|
500 mcg
|
Tablet
|
Anxiolytic
|
Pfizer Pharmaceuticals LLC
|
Puerto Rico
|
Automatic Renewal
|
16 April 2020
|
21 March 2025
|
| View |
|
DR-XY14608
|
Betaxolol (As Hydrochloride)
|
Betoptic S
|
2.5 mg/mL (0.25%)
|
Sterile Ophthalmic Suspension
|
-
|
Alcon-Couvreur NV
|
Belgium
|
-
|
06 April 2021
|
18 April 2026
|
| View |
|
DR-XY14670
|
5% Dextrose in 0.9% Sodium Chloride
|
Unbranded
|
(See Reverse)
|
Solution For Intravenous Infusion
|
Parenteral
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
17 April 2024
|
19 April 2029
|
| View |
|
DR-XY14672
|
0.9% Sodium Chloride
|
Unbranded
|
(See Reverse)
|
Solution For Intravenous Infusion
|
Parenteral
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
21 April 2024
|
12 April 2029
|
| View |
|
DR-XY14700
|
Aluminum Hydroxide + Magnesium Hydroxide
|
None
|
225mg/200mg
|
Suspension
|
ANTACID
|
AM-Europharma
Corporation
|
Philippines
|
Automatic Renewal
|
23 February 2022
|
09 July 2027
|